Synthesis of the blood circulating c-terminal fragment of insulin-like growth factor (IGF)-binding protein-4 in its native conformation -: Crystallization, heparin and IGF binding, and osteogenic activity

被引:14
作者
Fernández-Tornero, C
Lozano, RM
Rivas, G
Jiménez, MA
Ständker, L
Díaz-Gonzalez, D
Forssmann, WG
Cuevas, P
Romero, A
Giménez-Gallego, G
机构
[1] CSIC, Ctr Invest Biol, Dept Estructura & Func Prot, Madrid 28040, Spain
[2] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain
[3] IPF Pharmaceut GmbH, D-30625 Hannover, Germany
[4] Hosp Ramon & Cajal, Dept Invest, E-28034 Madrid, Spain
关键词
D O I
10.1074/jbc.M500587200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin-like growth factor-binding proteins play a critical role in a wide variety of important physiological processes. It has been demonstrated that both an N-terminal and a C-terminal fragment of insulin-like growth factor-binding protein-4 exist and accumulate in the circulatory system, these fragments accounting for virtually the whole amino acid sequence of the protein. The circulating C-terminal fragment establishes three disulfide bridges, and the binding pattern of these has recently been defined. Here we show that the monodimensional H-1 NMR spectrum of the C-terminal fragment is typical of a protein with a relatively close packed tertiary structure. This fragment can be produced in its native conformation in Escherichia coli, without the requirement of further refolding procedures, when synthesis is coupled to its secretion from the cell. The recombinant protein crystallizes with the unit cell parameters of a hexagonal system. Furthermore, it binds strongly to heparin, acquiring a well defined oligomeric structure that interacts with insulin-like growth factors, and promotes bone formation in cultures of murine calvariae.
引用
收藏
页码:18899 / 18907
页数:9
相关论文
共 56 条
[1]  
ARAI T, 1994, J BIOL CHEM, V269, P20388
[2]   Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix [J].
Arai, T ;
Busby, W ;
Clemmons, DR .
ENDOCRINOLOGY, 1996, 137 (11) :4571-4575
[3]   Reconstitution of a protein disulfide catalytic system [J].
Bader, M ;
Muse, W ;
Zander, T ;
Bardwell, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (17) :10302-10307
[4]   A PATHWAY FOR DISULFIDE BOND FORMATION INVIVO [J].
BARDWELL, JCA ;
LEE, JO ;
JANDER, G ;
MARTIN, N ;
BELIN, D ;
BECKWITH, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1038-1042
[5]   In vivo and in vitro function of the Escherichia coli periplasmic cysteine oxidoreductase DsbG [J].
Bessette, PH ;
Cotto, JJ ;
Gilbert, HF ;
Georgiou, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) :7784-7792
[6]  
Binoux Michel, 1999, V17, P281
[7]   IN-VIVO PROTEOLYSIS OF SERUM INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING PROTEIN-3 RESULTS IN INCREASED AVAILABILITY OF IGF TO TARGET-CELLS [J].
BLAT, C ;
VILLAUDY, J ;
BINOUX, M .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :2286-2290
[8]   Expression, purification and characterization of the structure and disulfide linkages of insulin-like growth factor binding protein-4 [J].
Chelius, D ;
Baldwin, MA ;
Lu, X ;
Spencer, EM .
JOURNAL OF ENDOCRINOLOGY, 2001, 168 (02) :283-296
[9]   PROTEOLYTIC CLEAVAGE OF INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN-4 (IGFBP-4) - LOCALIZATION OF CLEAVAGE SITE TO NONHOMOLOGOUS REGION OF NATIVE IGFBP-4 [J].
CHERNAUSEK, SD ;
SMITH, CE ;
DUFFIN, KL ;
BUSBY, WH ;
WRIGHT, G ;
CLEMMONS, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) :11377-11382
[10]  
Clemmons David R., 1999, V17, P273